Vascular Malformations and Hemangiomas
Vascular Malformations and Hemangiomas is a research topic within Surgery. Science Explorer counts 25k research works in it since 1950. 7.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the classification, diagnosis, and treatment of vascular anomalies, including hemangiomas, vascular malformations, and lymphatic malformations. It covers topics such as the use of propranolol and sirolimus in treating infantile hemangiomas, the genetic mutations associated with various syndromes, and the management of conditions like Sturge-Weber syndrome, PHACE syndrome, and Klippel-Trenaunay syndrome.
- Hemangiomas
- Vascular Malformations
- Propranolol
- PIK3CA Mutations
- Lymphatic Malformations
- Sturge-Weber Syndrome
- RASA1 Mutations
- Sirolimus
- PHACE Syndrome
- Klippel-Trenaunay Syndrome
- Research works
- 25k fractional, since 1950
- In the world top 10%
- 1.9k per year above
- Top-10% rate
- 7.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +21% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Vascular Malformations and Hemangiomas research?
By volume, the United States and China publish the most (921 and 580 works in 2022–2025).
By volume, 2022–2025
- 1 United States 921 works
- 2 China 580 works
- 3 India 523 works
- 4 Japan 293 works
- 5 Brazil 245 works
- 6 Spain 134 works
- 7 Italy 131 works
- 8 France 114 works
- 9 United Kingdom 114 works
- 10 Türkiye 110 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Vascular Malformations and Hemangiomas research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Vascular Malformations and Hemangiomas research, followed by Sichuan University and Shanghai Ninth People's Hospital.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 34 works
- 2 Sichuan UniversityChina 20 works
- 3 Shanghai Ninth People's HospitalChina 20 works
- 4 Children's Hospital of PhiladelphiaUnited States 17 works
- 5 Shanghai Jiao Tong UniversityChina 16 works
- 6 Post Graduate Institute of Medical Education and ResearchIndia 15 works
- 7 West China Hospital of Sichuan UniversityChina 15 works
- 8 Mohammed V UniversityMorocco 15 works
- 9 Johns Hopkins UniversityUnited States 14 works
- 10 Datta Meghe Institute of Higher Education and ResearchIndia 14 works
Where is Vascular Malformations and Hemangiomas research done?
The largest centres of Vascular Malformations and Hemangiomas research in 2022–2025 are Beijing (China), Shanghai (China), Tokyo (Japan) and New Delhi (India).
Largest cities, 2022–2025
Where is the best place to study Vascular Malformations and Hemangiomas?
Among universities, judged by research, All India Institute of Medical Sciences, Post Graduate Institute of Medical Education and Research and Datta Meghe Institute of Higher Education and Research score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | All India Institute of Medical SciencesIndia | 54.7 | 3.0% | 12.8× | 34 | +47.1% |
| 2 | Post Graduate Institute of Medical Education and ResearchIndia | 54.0 | 3.3% | 10.8× | 15 | +220.2% |
| 3 | Datta Meghe Institute of Higher Education and ResearchIndia | 48.2 | 7.4% | 13.4× | 14 | — |
| 4 | Sichuan UniversityChina | 43.7 | 14.2% | 2.7× | 20 | +66.4% |
| 5 | Mohammed V UniversityMorocco | 42.7 | 2.6% | 8.5× | 15 | +95.6% |
| 6 | Capital Medical UniversityChina | 39.6 | 9.3% | 5.0× | 13 | +101.3% |
| 7 | Baylor College of MedicineUnited States | 38.7 | 11.7% | 6.1× | 10 | +23.0% |
| 8 | Harvard UniversityUnited States | 37.5 | 17.7% | 2.1× | 12 | -18.4% |
| 9 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 37.4 | 7.5% | 3.1× | 13 | +174.5% |
| 10 | University of PennsylvaniaUnited States | 33.5 | 14.4% | 2.6× | 10 | +38.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Vascular Malformations and Hemangiomas research growing?
Output in 2018–2022 was 21% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Vascular Malformations and Hemangiomas.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.